VSBC · Vitaspring Biomedical Co. Ltd. · Debt
$0.01
At close · Feb 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that its plans, which depend on obtaining financing that is not within the Company's control, cannot be considered probable of being effectively implemented and therefore do not alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Sep 17, 2026
Market Cap
$2.30M
Shares
207.03M
Volume · Feb 12
408
Avg daily vol (1 sessions)
408
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-01-31 | USD 0 | 10-K filed 2026-06-17 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.